Private Ocean’s Alexion Pharmaceuticals ALXN Stock Holding History

Private Ocean’s Portfolio ALXN Stock Details ALXN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-27	Closed	-$3K	–	545
2017 Q4	$3K	Buy	+27	New	+$3.29K	﹤0.01%	337

Other funds holding ALXN

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Private Ocean's ALXN Position: Q1 2018 in Review

Private Ocean sold out of Alexion Pharmaceuticals (ALXN) in Q1 2018, closing a stake of 27 shares — an estimated $3K sold.

Private Ocean first reported a position in ALXN in Q4 2017 and held it in 1 quarter. The position peaked at $3K in Q4 2017. 596 funds tracked by Wall St. Rank hold ALXN as of Q1 2018.

Private Ocean reported no remaining Alexion Pharmaceuticals position as of Q1 2018 after selling out during the quarter.
Private Ocean sold 27 Alexion Pharmaceuticals shares in Q1 2018, an estimated $3K.
Private Ocean first reported a position in Alexion Pharmaceuticals in Q4 2017 and held it in 1 quarter.
Private Ocean's Alexion Pharmaceuticals position peaked at $3K in Q4 2017.
596 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q1 2018.

Based on Private Ocean's 13F filing for Q1 2018, filed 11 May 2018.